Dimensional Fund Advisors
ABCL icon

Dimensional Fund Advisors’s AbCellera Biologics ABCL Stock Holding History

Dimensional Fund Advisors’s Portfolio ABCL Stock Details ABCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-179,882
Closed -$532K – 3350
2024
Q2 		$532K Buy
179,882
+1,325
+0.7% +$5.01K ﹤0.01% 3018
2024
Q1 		$809K Buy
178,557
+83,990
+89% +$429K ﹤0.01% 2956
2023
Q4 		$540K Buy
94,567
+5,192
+6% +$24.1K ﹤0.01% 3033
2023
Q3 		$411K Buy
89,375
+1,308
+1% +$7.96K ﹤0.01% 3081
2023
Q2 		$569K Buy
88,067
+3,979
+5% +$27.2K ﹤0.01% 3034
2023
Q1 		$634K Sell
84,088
-2,580
-3% -$23.4K ﹤0.01% 2994
2022
Q4 		$878 Buy
86,668
+4,584
+6% +$53K ﹤0.01% 2926
2022
Q3 		$812K Buy
+82,084
New +$901K ﹤0.01% 2940

Other funds holding ABCL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return